Artwork

Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Will psychedelic assisted therapy become more accessible?

23:10
 
Share
 

Manage episode 412765585 series 5385
Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

It is nine months since changes to Therapeutic Goods Administration rules have enabled psychiatrists to treat patients for treatment resistant depression and PTSD using therapy augmented by psychedelic drugs.

Yet since that time, it is believed only a handful of treatments have taken place, and only nine psychiatrists have been registered to administer treatment using MDMA or Psilocybin. Meanwhile, this therapy is currently costing more than $20,000 per patient.

Those researching and providing clinical treatment believe it will become more accessible, and affordable, but only when stronger evidence of its effectiveness emerges.

  continue reading

2635 episodes

Artwork
iconShare
 
Manage episode 412765585 series 5385
Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

It is nine months since changes to Therapeutic Goods Administration rules have enabled psychiatrists to treat patients for treatment resistant depression and PTSD using therapy augmented by psychedelic drugs.

Yet since that time, it is believed only a handful of treatments have taken place, and only nine psychiatrists have been registered to administer treatment using MDMA or Psilocybin. Meanwhile, this therapy is currently costing more than $20,000 per patient.

Those researching and providing clinical treatment believe it will become more accessible, and affordable, but only when stronger evidence of its effectiveness emerges.

  continue reading

2635 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide